Preview
Unable to display preview. Download preview PDF.
Références
Lapins J, Jarstrand C, Emtestam L (1999) Coagulasenegative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 140(1): 90–5
Clemmensen OJ (1983) Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 22: 325–8
Jemec GB, Wendelboe P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39: 971–4
Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003; 4: 473–92
Krautheim A, Gollnick H (2003) Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 42: 1287–304
Parry MF, Rha CK (1986) Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 122: 583–4
Milstone EB, McDonald AJ, Scholhamer CF Jr. (1981) Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol; 117: 154–5
Gollnick H, Cunliffe W, Berson D et al. (2003) Management of acne. Topical retinoids. J Am Acad Dermatol 49(Suppl 1): S5–S11
Yu CC, Cook MG (1990) Hidradenitis suppurativa: a disease of follicular epithelium rather than apocrine glands. Br J Dermatol 122: 763–9
Attanoos R, Appleton MAC, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133: 254–8
Boer J, Weltevreden EF (1996) Hidradenitis suppurativa or acne inversa: a clinicopathological study of early lesions. Br J Dermatol 135: 721–5
Boer J, Dijkstra AT, Baar TJM (2201) Hidradenitis suppurativa (acne inversa): Lokale behandeling met resorcine. Ned Tijdschr Derm Venereol 11: 348–9
Boer J, Bos WH, Meer JB van der (2004) Hidradenitis suppurativa (acne inversa): behandeling met deroofing en resorcine (English abstract). Ned Tijdschr Derm Venereol 14: 274–8
Braun Falco O, Plewig G, Wolff HH et al. (1996) Diseases of the sebaceous Glands. In: Braun Falco O, Plewig G, Wolff HH, Burgdorf WHC (eds) Dermatology, 4th revised edn. Springer, Berlin Heidelberg New York pp 1051–82
Webster GF (2002) Acne vulgaris. Br Med J 325: 475–9
Stienstra P (1975) Hidradenitis suppurativa. In: Jansen LH (ed) Huid en geslachtsziekten. Scheltema en Holkema, Utrecht pp 121–5
Polano MK (1984) Topical therapeutics. Churchill Livingstone, Edinburgh
Groot de AC (2000) Dermatological drugs, topical agents and cosmetics. In: Dukes MNG, Aronson JK (eds) Meyler’s side effects of drugs, 14th edn. Elsevier, Amsterdam p 473
Degreef H, Hulsebos HJ, Mariën KJC et al. (2000) Behandelingsprincipes. In: Vloten WA, van, Degreef HJ, Stolz E, Vermeer BJ, Willemze R (eds) Dermatologie en Venereologie, 3rd edn. Elsevier, Amsterdam
Mills OH, Kligman AM (1982) Assay of comedolytic activity in acne patients. Acta Dermatovenereol 63: 68–71
Mills OH, Kligman AM (1983) Drugs that are ineffective in the treatment of acne vulgaris. Br J Dermatol 108: 371–4
Wüthrich B, Zabrodsky S, Storck H (1970) Perkutane Vergiftungen durch Resorcin, Salicylsäure und weisse Präcipitatsalbe. Pharmaceutica Acta Helvetiae 45: 453–60
Häckh G, Schwarzmüller E (1992) Codex dermatologischer Wirkstoffe. In: Niedner R, Ziegenmeyer J (eds) Dermatika. Wissenschaftliche Verlagsgesellschaft, Stuttgart pp 447–8
Werth von der JM, Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14: 389–92
Cunliffe WJ (2002) Looking back to the future-acne. Dermatology 204: 167–72
Cassano N, Alessandrini G, Mastrolonardo M et al. (1999) Peeling agents: toxicological and allergological aspects. J Eur Acad Dermatol Venereol 13: 14–23
Bontemps H, Mallaret M, Besson G et al. (1995) Confusion after topical use of resorcinol. Arch Dermatol 131: 112
Cunningham AA (1956) Resorcine poisoning. Arch Dis Child 31: 173–6
Plas M van der, Bos WH (1994) Chirurgische behandeling (epitheliale adnexcysten) door de dermatoloog (English abstract). Ned Tijdschr Derm Venereol 4: 101–3
Breathnach AS (1999) Azelaic acid: potential as a general antitumoural agent. Med Hypotheses 52: 221–6
Brasch J, Christophers E (1993) Azelaic acid has antimycotic properties in vitro. Dermatology 186: 55–8
Detmar M, Mayer-da-Silva A, Stadler R (1989) Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 93: 70–4
Topert M, Rach P, Siegmund F (1989) Pharmacology and toxicology of azelaic acid. Acta Dermatol Venereol Suppl (Stockh) 143: 14–9
Passi S, Picardo M, Mingrone G et al. (1989) Azelaic acid-biochemistry and metabolism. Acta Dermatol Venereol Suppl (Stockh) 143: 8–13
Galhaup I (1989) Azelaic acid: mode of action at cellular and subcellular levels. Acta Dermatol Venereol Suppl (Stockh) 143: 75–82
Bojar RA, Holland KT, Leeming JP, Cunliffe WJ (1988) Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047. J Appl Bacteriol 64: 497–504
Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol 1998;139[Suppl] 53: 37–40
Levine RM, Rasmussen JE (1983) Intralesional corticosteroids in the treatment of nodulocystic acne. Arch Dermatol 119: 480–1
Jansen T, Romiti R, Plewig G, Altmeyer P (2000) Disfiguring draining sinus tracts in a female acne patient. Pediatr Dermatol 17: 123–5
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag France, Paris,
About this chapter
Cite this chapter
Sartorius, K., Boer, J., Jemec, G.B.E. (2008). Traitement topique. In: Hidradénite suppurée. Springer, Paris. https://doi.org/10.1007/978-2-287-72063-5_21
Download citation
DOI: https://doi.org/10.1007/978-2-287-72063-5_21
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72062-8
Online ISBN: 978-2-287-72063-5